Battle royal in biotechnology: R&D vs. product vs. process innovations
dc.contributor.author | Nicolau, Juan Luis | en |
dc.contributor.author | Santa-María, María Jesús | en |
dc.date.accessioned | 2024-08-01T18:58:14Z | en |
dc.date.available | 2024-08-01T18:58:14Z | en |
dc.date.issued | 2015-02-13 | en |
dc.description.abstract | Companies regard innovation as a central element of their business. However, as not all innovation types are the same, the central question is: should their announcements bring about the same effect on performance? This article analyses potential differences in firm value derived from the innovation-type announcements ‘R&D’, ‘product’, and ‘process’, made by intensive news-generating firms such as biotech companies. The empirical application shows a significantly positive reaction to innovation announcements, with the prospect of future innovation (‘R&D’ investment announcements) having greater impact on firm value than ‘product’ and ‘process’ innovations. Firm experience also acts as a moderator in this innovation–performance relationship, which is particularly relevant for entrepreneurs who need to develop and send credible signals indicating the value of the firm's intangible assets to the market. | en |
dc.description.version | Accepted version | en |
dc.format.extent | Pages 503-516 | en |
dc.format.extent | 14 page(s) | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.1080/09537325.2015.1012056 | en |
dc.identifier.eissn | 1465-3990 | en |
dc.identifier.issn | 0953-7325 | en |
dc.identifier.issue | 5 | en |
dc.identifier.orcid | Nicolau Gonzalbez, Juan [0000-0003-0048-2823] | en |
dc.identifier.uri | https://hdl.handle.net/10919/120824 | en |
dc.identifier.volume | 27 | en |
dc.language.iso | en | en |
dc.publisher | Routledge | en |
dc.relation.uri | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352308600002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=930d57c9ac61a043676db62af60056c1 | en |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | firm age | en |
dc.subject | biotechnology | en |
dc.subject | R&D | en |
dc.subject | innovation | en |
dc.subject | firm value | en |
dc.title | Battle royal in biotechnology: R&D vs. product vs. process innovations | en |
dc.title.serial | Technology Analysis & Strategic Management | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.other | Article | en |
dcterms.dateAccepted | 2015-01-20 | en |
pubs.organisational-group | /Virginia Tech | en |
pubs.organisational-group | /Virginia Tech/Pamplin College of Business | en |
pubs.organisational-group | /Virginia Tech/Pamplin College of Business/Hospitality and Tourism Management | en |
pubs.organisational-group | /Virginia Tech/All T&R Faculty | en |
pubs.organisational-group | /Virginia Tech/Pamplin College of Business/PCOB T&R Faculty | en |